Log In
Print
BCIQ
Print
Print this Print this
 

fenofibric acid, TriLipix

Also known as: SLV348 (ABT-335)

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionPeroxisome proliferation activated receptor (PPAR) alpha agonist
Molecular Target Peroxisome proliferation activated receptor (PPAR) alpha
Mechanism of ActionPeroxisome proliferation activated receptor (PPAR) alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDyslipidemia
Indication DetailsTreat mixed dyslipidemia
Regulatory Designation
Partner AbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$6,507.8M

$6,100.0M

$407.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today